Radiotherapy plus EGFR inhibitors: synergistic modalities

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2059-7347

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Radiotherapy plus EGFR inhibitors: synergistic modalities ; volume:2 ; number:1 ; day:18 ; month:1 ; year:2017 ; pages:1-9 ; date:12.2017
Cancers of the head & neck ; 2, Heft 1 (18.1.2017), 1-9, 12.2017

Keyword: Krebs
Onkologie

Creator: Bossi, Paolo

Contributor: Platini, Francesca
SpringerLink (Online service)

DOI: 10.1186/s41199-016-0020-y

URN: urn:nbn:de:1111-201702154993

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:46 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Bossi, Paolo
Platini, Francesca
SpringerLink (Online service)

Other Objects (12)

Synergistic cytotoxicity of the CDK4 inhibitor Fascaplysin in combination with EGFR inhibitor Afatinib against Non-small Cell Lung Cancer

Physical modalities in dermatologic therapy : radiotherapy, electrosurgery, phototherapy, cryosurgery

Dosimetric comparison of different treatment modalities for stereotactic radiotherapy

The allosteric AKT inhibitor MK2206 shows a synergistic interaction with chemotherapy and radiotherapy in glioblastoma spheroid cultures

Direct GPCR-EGFR interaction enables synergistic membrane-to-nucleus information transfer

Alethic Modalities, Temporal Modalities, and Representation

Synergistic Effects of Gold Nanocages in Hyperthermia and Radiotherapy Treatment

Hochschulschrift

Design, Synthese und Optimierung neuer mutationsspezifischer EGFR Inhibitoren

Tarsoconjunctival Granulation Tissue Formation Associated with EGFR Inhibitors

EGFR-antagonistic affibody-functionalized Pt-based nanozyme for enhanced tumor radiotherapy

The EGFR-STYK1-FGF1 axis sustains functional drug tolerance to EGFR inhibitors in EGFR-mutant non-small cell lung cancer

Overcoming EGFR G724S-mediated osimertinib resistance through unique binding characteristics of second-generation EGFR inhibitors

Synergistic cytotoxicity of the CDK4 inhibitor Fascaplysin in combination with EGFR inhibitor Afatinib against Non-small Cell Lung Cancer

Physical modalities in dermatologic therapy : radiotherapy, electrosurgery, phototherapy, cryosurgery

Dosimetric comparison of different treatment modalities for stereotactic radiotherapy

The allosteric AKT inhibitor MK2206 shows a synergistic interaction with chemotherapy and radiotherapy in glioblastoma spheroid cultures

Direct GPCR-EGFR interaction enables synergistic membrane-to-nucleus information transfer

Alethic Modalities, Temporal Modalities, and Representation

Synergistic Effects of Gold Nanocages in Hyperthermia and Radiotherapy Treatment

Hochschulschrift

Design, Synthese und Optimierung neuer mutationsspezifischer EGFR Inhibitoren

Tarsoconjunctival Granulation Tissue Formation Associated with EGFR Inhibitors

EGFR-antagonistic affibody-functionalized Pt-based nanozyme for enhanced tumor radiotherapy

The EGFR-STYK1-FGF1 axis sustains functional drug tolerance to EGFR inhibitors in EGFR-mutant non-small cell lung cancer

Overcoming EGFR G724S-mediated osimertinib resistance through unique binding characteristics of second-generation EGFR inhibitors

Synergistic cytotoxicity of the CDK4 inhibitor Fascaplysin in combination with EGFR inhibitor Afatinib against Non-small Cell Lung Cancer

Physical modalities in dermatologic therapy : radiotherapy, electrosurgery, phototherapy, cryosurgery

Dosimetric comparison of different treatment modalities for stereotactic radiotherapy

The allosteric AKT inhibitor MK2206 shows a synergistic interaction with chemotherapy and radiotherapy in glioblastoma spheroid cultures

Direct GPCR-EGFR interaction enables synergistic membrane-to-nucleus information transfer

Alethic Modalities, Temporal Modalities, and Representation

Synergistic Effects of Gold Nanocages in Hyperthermia and Radiotherapy Treatment

Hochschulschrift

Design, Synthese und Optimierung neuer mutationsspezifischer EGFR Inhibitoren

Tarsoconjunctival Granulation Tissue Formation Associated with EGFR Inhibitors

EGFR-antagonistic affibody-functionalized Pt-based nanozyme for enhanced tumor radiotherapy

The EGFR-STYK1-FGF1 axis sustains functional drug tolerance to EGFR inhibitors in EGFR-mutant non-small cell lung cancer

Overcoming EGFR G724S-mediated osimertinib resistance through unique binding characteristics of second-generation EGFR inhibitors

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Radiotherapy plus EGFR inhibitors: synergistic modalities

Object Details

References and Relationships

Classification and Topics

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Synergistic cytotoxicity of the CDK4 inhibitor Fascaplysin in combination with EGFR inhibitor Afatinib against Non-small Cell Lung Cancer

Physical modalities in dermatologic therapy : radiotherapy, electrosurgery, phototherapy, cryosurgery

Dosimetric comparison of different treatment modalities for stereotactic radiotherapy

The allosteric AKT inhibitor MK2206 shows a synergistic interaction with chemotherapy and radiotherapy in glioblastoma spheroid cultures

Direct GPCR-EGFR interaction enables synergistic membrane-to-nucleus information transfer

Alethic Modalities, Temporal Modalities, and Representation

Synergistic Effects of Gold Nanocages in Hyperthermia and Radiotherapy Treatment

Design, Synthese und Optimierung neuer mutationsspezifischer EGFR Inhibitoren

Tarsoconjunctival Granulation Tissue Formation Associated with EGFR Inhibitors

EGFR-antagonistic affibody-functionalized Pt-based nanozyme for enhanced tumor radiotherapy

The EGFR-STYK1-FGF1 axis sustains functional drug tolerance to EGFR inhibitors in EGFR-mutant non-small cell lung cancer

Overcoming EGFR G724S-mediated osimertinib resistance through unique binding characteristics of second-generation EGFR inhibitors

Synergistic cytotoxicity of the CDK4 inhibitor Fascaplysin in combination with EGFR inhibitor Afatinib against Non-small Cell Lung Cancer

Physical modalities in dermatologic therapy : radiotherapy, electrosurgery, phototherapy, cryosurgery

Dosimetric comparison of different treatment modalities for stereotactic radiotherapy

The allosteric AKT inhibitor MK2206 shows a synergistic interaction with chemotherapy and radiotherapy in glioblastoma spheroid cultures

Direct GPCR-EGFR interaction enables synergistic membrane-to-nucleus information transfer

Alethic Modalities, Temporal Modalities, and Representation

Synergistic Effects of Gold Nanocages in Hyperthermia and Radiotherapy Treatment

Design, Synthese und Optimierung neuer mutationsspezifischer EGFR Inhibitoren

Tarsoconjunctival Granulation Tissue Formation Associated with EGFR Inhibitors

EGFR-antagonistic affibody-functionalized Pt-based nanozyme for enhanced tumor radiotherapy

The EGFR-STYK1-FGF1 axis sustains functional drug tolerance to EGFR inhibitors in EGFR-mutant non-small cell lung cancer

Overcoming EGFR G724S-mediated osimertinib resistance through unique binding characteristics of second-generation EGFR inhibitors

Synergistic cytotoxicity of the CDK4 inhibitor Fascaplysin in combination with EGFR inhibitor Afatinib against Non-small Cell Lung Cancer

Physical modalities in dermatologic therapy : radiotherapy, electrosurgery, phototherapy, cryosurgery

Dosimetric comparison of different treatment modalities for stereotactic radiotherapy

The allosteric AKT inhibitor MK2206 shows a synergistic interaction with chemotherapy and radiotherapy in glioblastoma spheroid cultures

Direct GPCR-EGFR interaction enables synergistic membrane-to-nucleus information transfer

Alethic Modalities, Temporal Modalities, and Representation

Synergistic Effects of Gold Nanocages in Hyperthermia and Radiotherapy Treatment

Design, Synthese und Optimierung neuer mutationsspezifischer EGFR Inhibitoren

Tarsoconjunctival Granulation Tissue Formation Associated with EGFR Inhibitors

EGFR-antagonistic affibody-functionalized Pt-based nanozyme for enhanced tumor radiotherapy

The EGFR-STYK1-FGF1 axis sustains functional drug tolerance to EGFR inhibitors in EGFR-mutant non-small cell lung cancer

Overcoming EGFR G724S-mediated osimertinib resistance through unique binding characteristics of second-generation EGFR inhibitors

Related objects

Reset password